Resources with keywords: side-effects
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA Netw Open. 2022;5(4):e228879. doi:10.1001/jamanetworkopen.2022.8879
Hanson KE, Goddard K, Lewis N, et al.
Surveillance data from the Vaccine Safety Datalink showed increased incidence rate of confirmed GBS 1 to 21 days after receiving the Ad.26.COV2.S (Janssen).
Good summary of vaccine information (elegibility, ages, boosters, side effects, safety, etc.).